跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 111,781 条关于
“Advanced endometrial cancer”
全部
111,781
临床试验
87,216
药物
2,296
机构
1,239
资讯
21,030
去年
Navigating Advanced Endometrial Cancer Treatment: Expert Guidance for Community Oncologists
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
去年
Cadonilimab Plus Lenvatinib Shows Promise in Advanced Endometrial Cancer After Platinum Failure
去年
NICE Discontinues Review of Lenvatinib-Pembrolizumab Combination for Advanced Endometrial Cancer
2年前
Keytruda Gains 40th FDA Approval for Advanced Endometrial Cancer Treatment
去年
E7386 Shows Promising Results in Advanced Endometrial Cancer Trial with 30% Response Rate
去年
Immunotherapy Plus Chemotherapy Redefines Frontline Treatment for Advanced Endometrial Cancer
去年
Fruquintinib Plus Sintilimab Conditionally Approved in China for Advanced pMMR Endometrial Cancer
去年
LEAP-001 Trial: Lenvatinib and Pembrolizumab Combination Fails to Improve Survival in Advanced Endometrial Cancer
2年前
Pembrolizumab Plus Lenvatinib Fails to Meet Survival Endpoints in Advanced Endometrial Cancer
第 1 页，共 2103 页
上一页
下一页
